Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8721)
All Articles published online
|
Publishing Process of This Article
|
Sep 7, 2016 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Murata A, Genda T, Ichida T, Amano N, Sato S, Tsuzura H, Sato S, Narita Y, Kanemitsu Y, Shimada Y, Hirano K, Iijima K, Wada R, Nagahara A, Watanabe S. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. World J Gastroenterol 2016; 22(33): 7569-7578 [PMID: 27672277 DOI: 10.3748/wjg.v22.i33.7569] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i33/7569.htm |
| Number | Citing Articles |
| 1 |
Cleverson T. Soares, Luciana R. V. Fachin, Ana P. F. Trombone, Patricia S. Rosa, Cássio C. Ghidella, Andrea F. F. Belone. Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction. Frontiers in Medicine 2018; 5 doi: 10.3389/fmed.2018.00263
|
| 2 |
Chao Han, Lanzhu Gao, Han Bai, Xiaoguang Dou. Identification of a role for serum aldo‑keto reductase family 1 member B10 in early detection of hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9547
|
| 3 |
Manar Atyah, Yi-Rui Yin, Chen-Hao Zhou, Qiang Zhou, Wan-Yong Chen, Qiong-Zhu Dong, Ning Ren. Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma. Aging 2018; 10(8): 2079 doi: 10.18632/aging.101531
|
| 4 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 5 |
Junqing Wang, Yunyun Zhou, Xiaochun Fei, Xuehua Chen, Yongjun Chen. Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29271-3
|
| 6 |
Shunsuke Sato, Hironori Tsuzura, Yuji Kita, Yuji Ikeda, Daishi Kabemura, Sho Sato, Nozomi Amano, Noboru Yatagai, Ayato Murata, Yuji Shimada, Takuya Genda. Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication. JGH Open 2021; 5(10): 1203 doi: 10.1002/jgh3.12655
|
| 7 |
Xu Ye, Cunyan Li, Xuyu Zu, Minglin Lin, Qiang Liu, Jianghua Liu, Guoguo Xu, Zhiyong Chen, Yongliang Xu, Long Liu, Diteng Luo, Zhe Cao, Guiyuan Shi, Zirui Feng, Hongyu Deng, Qianjin Liao, Chuan Cai, Duan‐Fang Liao, Jing Wang, Junfei Jin, Deliang Cao. A Large‐Scale Multicenter Study Validates Aldo‐Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma. Hepatology 2019; 69(6): 2489 doi: 10.1002/hep.30519
|
| 8 |
Johanna K. DiStefano, Bethany Davis. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma. Cancers 2019; 11(4): 486 doi: 10.3390/cancers11040486
|
| 9 |
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. Journal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
|
| 10 |
Chenglin Xie, Xu Ye, Li Zeng, Xi Zeng, Deliang Cao. Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma. Journal of Gastroenterology 2023; 58(10): 1030 doi: 10.1007/s00535-023-02011-9
|
| 11 |
Abdel-Naser Abdel-Atty Gadallah, Ehab Ahmed Abdel Atti, Tary Abdel Hamid Salman, Abd elSamie Othman Hassan, Hanan M. Bedair. Predictive Role for Serum Aldo-Keto Reductase Family1 Member B10 for Early Detection of Hepatocellular Carcinoma in Egyptian Patients. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 1678 doi: 10.3889/oamjms.2022.7149
|
| 12 |
Ziran Wang, Lingjun Kong, Rui Zhang, Xiaobo Yang, Zhe Cao, Tengda Xu, Han Zhang, Yaling Dou. Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 131 doi: 10.2147/JHC.S443006
|
| 13 |
Huiwen Wang, Jian Zhang, Jinqing Liu, Yongfang Jiang, Lei Fu, Shifang Peng. Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1124956
|
| 14 |
Huanqin Li, Shumin Liu, Yun Lin, Xiongfei Shi, Na Du, Jing Yao, Ruiyang Liu, Yan Du, Kai Yang. Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma. Intervirology 2022; 65(4): 195 doi: 10.1159/000525543
|